| Literature DB >> 23863595 |
Hiroaki Furuyama1, Hiroaki Fuji, Shinya Okumura, Tatsuhito Nishigori, Yoshio Kadokawa, Masato Kondo, Takafumi Machimoto, Yoshito Asao, Tsunehiro Yoshimura.
Abstract
A 48-year-old man was administered bevacizumab+FOLFOX for lymph node recurrence of colon cancer in the abdominal cavity, and developed serious thrombosis of the portal system after 6 courses of the chemotherapy. We discontinued it promptly and anticoagulant therapy with urokinase was started immediately, but a complete dissolution was not achieved. Preservation therapy using anticoagulants for a long duration was effective for controling the of clinical symptom of thrombosis. The result of 6 courses of chemotherapy was CR, and the effect continues today, without further treatment 2 years later.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23863595
Source DB: PubMed Journal: Gan To Kagaku Ryoho ISSN: 0385-0684